Search Results - "Piera Carbonell, A"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Recommendations for thromboembolic disease in oncological processes. A view from primary care by García Vallejo, O, Aicart Bort, M D, Babiano Fernández, M Á, Caballer Rodilla, J, Cabrera Ferriols, M Á, Carrasco Carrasco, E, Gil Gil, I, Lahera García, A M, Cardenas Tamara, M, Piera Carbonell, A

    Published in Semergen, medicina de familia (01-10-2023)
    “…Venous thromboembolic disease (VTE) is a frequent complication in patients diagnosed with cancer and a cause of morbidity and mortality. Approximately 20% of…”
    Get full text
    Journal Article
  2. 2

    Home blood pressure self-measurement: “Current situation and new perspectives” by Divisón-Garrote, J.A., Velilla-Zancada, S., Artigao-Rodenas, L.M., García-Lerín, A., Vicente-Molinero, A., Piera Carbonell, A.M., Alonso-Moreno, F.J., Crespo-Sabarís, R., Valls-Roca, F., Martín-Rioboó, E., Pallarés-Carratala, V.

    Published in Hipertension y riesgo vascular (01-04-2023)
    “…The method typically used to diagnose and monitor hypertensive patients has been to measure blood pressure in the physician's surgery; however, it is a…”
    Get full text
    Journal Article
  3. 3

    COVID-19 and thromboprophylaxis: Recommendations for our clinical practice in Primary Care by Piera Carbonell, A, Frías Vargas, M, García Vallejo, O, García Lerín, A, Cabrera Ferriols, M A, Peiró Morant, J, Carrasco Carrasco, E

    Published in Semergen, medicina de familia (01-10-2020)
    “…The new coronavirus (SARS-CoV-2) is responsible for a severe acute respiratory syndrome. Among its manifestations, it can develop a thrombotic disease, both…”
    Get full text
    Journal Article
  4. 4

    Knowledge of thromboprophylaxis-COVID-19 in healthcare professionals in Spain by García Vallejo, O, Frías Vargas, M, Gil Gil, I, Vázquez Gómez, N, Piera Carbonell, A, Peiró Morant, J

    Published in Semergen, medicina de familia (01-09-2021)
    “…Patients suffering from coronavirus infection have an increased risk of venous thromboembolic disease (VTE) associated with COVID-19, which confers a higher…”
    Get full text
    Journal Article
  5. 5

    Management of type 2 diabetes mellitus in adolescents and young adults in primary care by Miravet-Jiménez, S, Pérez-Unanua, M P, Alonso-Fernández, M, Escobar-Lavado, F J, González-Mohino Loro, B, Piera-Carbonell, A

    Published in Semergen, medicina de familia (01-09-2020)
    “…The prevalence of type 2 diabetes (DM2) diagnosed in childhood and adolescence is currently increasing, and is characterised by a rapidly progressive decline…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Conocimiento de la tromboprofilaxis-COVID-19 en los profesionales sanitarios en España by García Vallejo, O., Frías Vargas, M., Gil Gil, I., Vázquez Gómez, N., Piera Carbonell, A., Peiró Morant, J.

    Published in Semergen, medicina de familia (01-09-2021)
    “…Los pacientes que padecen infección por coronavirus presentan un riesgo aumentado de enfermedad tromboembólica venosa (ETEV) asociada a la COVID-19, lo cual…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Manejo de la diabetes mellitus tipo 2 en adolescentes y adultos jóvenes en atención primaria by Miravet-Jiménez, S., Pérez-Unanua, M.P., Alonso-Fernández, M., Escobar-Lavado, F.J., González-Mohino Loro, B., Piera-Carbonell, A.

    Published in Semergen, medicina de familia (01-09-2020)
    “…La prevalencia de la diabetes tipo 2 diagnosticada en la infancia/juventud está aumentando y se caracteriza por una disminución acelerada de la función de las…”
    Get full text
    Journal Article
  17. 17

    COVID-19 y tromboprofilaxis: recomendaciones para nuestra práctica clínica en Atención Primaria by Piera Carbonell, A., Frías Vargas, M., García Vallejo, O., García Lerín, A., Cabrera Ferriols, M.A., Peiró Morant, J., Carrasco Carrasco, E.

    Published in Semergen, medicina de familia (01-10-2020)
    “…El nuevo coronavirus (SARS-CoV-2) es el responsable de un síndrome respiratorio agudo severo (SARS). Entre sus manifestaciones puede desarrollar una enfermedad…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20